Large cell carcinoma of the lung future or investigational therapies: Difference between revisions
(Created page with "__NOTOC__ {{Large cell carcinoma of the lung }} {{CMG}}; {{AE}} {{MV}} ==Overview== ==Future or Investigational Therapies== ==References== {{reflist|2}} {{WikiDoc Help Me...") |
(Mahshid) |
||
(One intermediate revision by one other user not shown) | |||
Line 7: | Line 7: | ||
==Future or Investigational Therapies== | ==Future or Investigational Therapies== | ||
Novel trials of large cell carcinoma of the lung, include: | |||
*Multicentre phase II study of cisplatin-etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study. | |||
==References== | ==References== | ||
Line 19: | Line 21: | ||
[[Category:Lung cancer]] | [[Category:Lung cancer]] | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Pulmonology]] | |||
[[Category:Surgery]] |
Latest revision as of 02:11, 27 November 2017
Large Cell Carcinoma of the Lung Microchapters |
Differentiating Large Cell Carcinoma of the Lung from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Large cell carcinoma of the lung future or investigational therapies On the Web |
American Roentgen Ray Society Images of Large cell carcinoma of the lung future or investigational therapies |
FDA on Large cell carcinoma of the lung future or investigational therapies |
CDC on Large cell carcinoma of the lung future or investigational therapies |
Large cell carcinoma of the lung future or investigational therapies in the news |
Blogs on Large cell carcinoma of the lung future or investigational therapies |
Directions to Hospitals Treating Large cell carcinoma of the lung |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]
Overview
Future or Investigational Therapies
Novel trials of large cell carcinoma of the lung, include:
- Multicentre phase II study of cisplatin-etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study.